Solvay Shares Rise After Solid Annual Results and Industrial Adjustment in Spain
Solvay's stock is up 0.86% this Wednesday morning, at 28.12 euros, following the announcement of its 2025 annual results and an updated recommendation from KBC Securities. The Belgian chemical company also announced a reduction in capacity at its Torrelavega site in Spain, amid a challenging global market for soda ash.
Annual Financial Performance and Industrial Strategy
On Tuesday, Solvay disclosed its annual accounts for 2025, reporting a robust generation of free cash flow and maintaining a satisfactory EBITDA margin. These results were achieved despite persistent weak demand and an uncertain geopolitical environment, both of which weigh on the entire European chemical sector. In parallel, the group announced a reduction in its soda ash production capacity in Torrelavega, Spain. This decision addresses a sustained global oversupply in the market and high energy costs across the continent. The industrial adjustment reflects the group's intention to preserve profitability in an unfavorable cycle, while adapting its production tools to market realities. The next quarterly reports, expected on May 7, will assess the impact of these decisions on the operational trajectory of the Belgian chemist.
Technical Analysis and Market Position
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Technically, the stock shows a short-term upward trend, having significantly detached from its 50-day moving average, currently at 26.79 euros. This pattern indicates a rising momentum over several weeks, with the stock also crossing its 200-day moving average (27.81 euros). However, the stock is approaching a resistance at 28.50 euros, a threshold whose crossing could determine the continuation of the movement. Regarding analyst recommendations, KBC Securities issued a 'hold' rating on the stock on February 24, without disclosing a price target. This cautious stance comes in the wake of the annual results publication. Over one year, the stock's performance remains down by 10.67%, reflecting the structural difficulties of the European chemical sector and the macroeconomic context impacting industrial demand.
Challenging market environment, excluding potential recovery measures from Sadara, updated guidance reflects Middle East impact
Risks mentioned
Middle East conflict impact of approximately €-25 million on underlying EBITDA in Q3 2026
Continued shutdown of the Peroxide plant at the Sadara complex in Jubail, Saudi Arabia accounted for €-15 million in Q3 2026
Challenging market environment affecting Group performance in Q3 2026
Opportunities identified
Joint venture contractual framework includes mechanisms designed to recover lost profitability from Sadara shutdown
Group exploring all available avenues to mitigate financial impact of shutdown
Transformation program and focus on cash generation and cost savings targets
Outlook / guidance
Expected EBITDA: 730 millions d'euros
Management commentary: In light of these developments, Solvay has reviewed its full-year 2026 guidance. Excluding potential revenue or recovery measures from Sadara for the remainder of 2026, the updated guidance is: Underlying EBITDA between €720 and €740 million
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.